Analysis of the Association between Copy Number Variation and Ventricular Fibrillation in ST-Elevation Acute...

Area of Science:

• Cardiovascular Genetics
• Genomics
• Molecular Cardiology

Background:

• Sudden cardiac death from ventricular fibrillation (VF) during ST-elevation acute myocardial infarction (STEAMI) is a major cause of cardiovascular mortality.
• Genetic factors contribute to VF, but copy number variations (CNVs) remain understudied in this context.
• Understanding genetic underpinnings of VF in STEAMI is crucial for risk stratification and prevention.

Purpose of the Study:

• To investigate the role of copy number variations (CNVs) in patients experiencing ventricular fibrillation (VF) during ST-elevation acute myocardial infarction (STEAMI).
• To identify specific CNVs associated with an increased risk of VF in the STEAMI population.

Main Methods:

• Whole exome sequencing was performed on a cohort of 39 patients with STEAMI and VF.
• Copy number variation analysis was conducted to identify deletions and duplications in the exonic regions.
• Gene-specific CNV analysis was performed, focusing on variations with an average gene copy number of four or more.

Main Results:

• CNVs, including duplications in PARP2 and TTC5, and deletions in MUC15 and PPP6R1, were identified.
• These CNVs may serve as potential risk indicators for VF during STEAMI.
• Notable CNVs (average gene copy number ≥4) were observed in DEFB134, FCGR2C, GREM1, PARM1, SCG5, and UNC79 genes.

Conclusions:

• Copy number variations play a role in the pathophysiology of ventricular fibrillation in ST-elevation acute myocardial infarction.
• Specific CNVs in genes such as PARP2, TTC5, MUC15, and PPP6R1 are associated with VF risk in STEAMI patients.
• Further research into CNVs could lead to novel biomarkers for predicting VF in acute myocardial infarction.